Foresight News 消息，美股制药公司 Processa （纳斯达克：PCSA）宣布获得战略投资，具体融资金额未披露，且其正在评估企业加密货币财务策略。该公司已聘请 LifeSci Capital 担任顾问，协助实施相关策略。 Processa 表示将在严格遵守监管标准的前提下，探索利用区块链资产支持其临床开发项目。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.